Nuclear Localisation of the Endocannabinoid Metabolizing Enzyme Fatty Acid Amide Hydrolase (FAAH) in Invasive Trophoblasts and an Association with Recurrent Miscarriage

Chamley, L.W.; Bhalla, A.; Stone, P.R.; Liddell, H.; O'Carroll, S.; Kearn, C.; Glass, M.

doi:10.1016/j.placenta.2008.08.003

« Previous Next »Placenta
Volume 29, Issue 11 , Pages 970-975, November 2008

Nuclear Localisation of the Endocannabinoid Metabolizing Enzyme Fatty Acid Amide Hydrolase (FAAH) in Invasive Trophoblasts and an Association with Recurrent Miscarriage

L.W. Chamley
- Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand
- Fertility Plus, Auckland District Health Board, Auckland, New Zealand
- Corresponding author. Department of Obstetrics and Gynaecology, University of Auckland, Private Bag, 92019 Auckland, New Zealand.
A. Bhalla
- Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand
P.R. Stone
- Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand
H. Liddell
- Recurrent Miscarriages Clinic, National Women's Hospital, Auckland District Health Board, Auckland, New Zealand
S. O'Carroll
- Department of Anatomy, University of Auckland, Auckland, New Zealand
C. Kearn
- Department of Anesthesiology, University of Washington, Seattle, WA, USA
M. Glass
- Department of Pharmacology, University of Auckland, Auckland, New Zealand

Accepted 6 August 2008. published online 22 September 2008.

Abstract

Endocannabiniods are lipid signalling molecules that are related to the major psychoactive component in marijuana, delta-9-tetrahydrocannabinol and are increasingly recognized as being important in implantation and development of early embryos. The endocannabinoid anandamide, is metabolized by the enzyme fatty acid amide hydrolase (FAAH), and insufficient levels of this enzyme have been implicated in spontaneous miscarriage in women and implantation failure in mice.

We screened placental bed biopsies and placental tissue from 45 women with recurrent miscarriage and 17 gestation-matched women with normal pregnancies for the expression of FAAH by immunohistochemistry. Unexpectedly, the enzyme appeared to be localised to the nucleus of trophoblasts and this was confirmed by western blotting of sub-cellular fractions and confocal microscopy. FAAH was expressed in the cytoplasm of large decidual stromal cells and significantly more women with recurrent miscarriage (73%) expressed FAAH in these cells than women with normal pregnancy (31%). FAAH was also expressed in the nucleus of extravillous trophoblasts that had invaded the decidua from 67% of women with recurrent miscarriage but was not expressed by these cells in any women with normal pregnancies. In contrast, FAAH was expressed in extravillous trophoblasts that had migrated out of the villi but that had not yet invaded the decidua in both normal pregnancies and in cases of recurrent miscarriage. FAAH was also present in the nucleus of a small number of villous trophoblasts in some specimens.

FAAH appears to be over expressed in trophoblasts that have invaded the decidua, as well as in large decidual stromal cells in many cases of recurrent miscarriage. This may reflect inadequate control of the cannabinoid system in the uterus of women who experience recurrent miscarriages. The functional significance of the unexpected nuclear localisation of FAAH in trophoblasts is not yet clear.

Keywords: Recurrent miscarriage, Trophoblast, Cannabinoid, Fatty acid amide hydrolase, Decidua, Immunohistochemistry